Treatment for Vulva and Cervical Diseases: New Options Past Meetings ISMIVS

Treatment for Vulva and Cervical Diseases: New Options

2022 APAGE-ISMIVS HIFU Series Webinars

EP3

The 3rd episode of 2022 APAGE-ISMIVS HIFU Series Webinars, themed "Treatment for vulva and cervical diseases: new options", was successfully held on July, 21st. This episode, chaired by Dr. Peng-Teng Chua and Prof. Felix Wong, shed light on new options for treating vulva and cervical diseases.

The seminar was joined by Prof. Chyi-long Lee, Prof. Li Chengzhi, Prof. Apolikhina Inna Anatolievna and Dr. Teterina Tatiana, and Prof. Kuan-Gen Huang. In opening remarks, Prof. Chyi-long Lee, the Chairman of the Board of Trustees of APAGE, stressed the significance of the Webinars in sharing knowledge and experience and delivering the latest development in gynaecology and expressed his sincere hope for a fruitful event.

Prof. Li Chengzhi from Chongqing Medical University discussed focused ultrasound surgery (FUS) as a new way to treat high-risk HPV infection and CIN. At first, she introduced the principles and characteristics of FUS and stressed its advantages in real-time monitoring and dose adjustment, and then made a detailed presentation on the application of focused ultrasound in HR-HPV infection and CIN, including the indications and contraindications, preparation before the treatment and how to carry out the therapy. She also shared some clinical observations of FU therapy for cervical diseases and compared FUS with laser, drug and other therapies. At last, she showed some cases and the pathological changes in the cervix before and after FUS, reaching the conclusion that focused ultrasound can safely and effectively treat HR-HPV infection and cervical lesions.

Prof. Apolikhina Inna Anatolievna and Dr. Teterina Tatiana, from National Medical Research Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov, shared their experience with HIFU treatment for non-neoplastic epithelial disorders of the vulva. Prof. Inna mentioned that lichen sclerosis was observed at a higher incidence rate in younger women in recent years. She compared HIFU treatment with fractional laser and emphasized the advantages of HIFU in the alleviation of symptoms and improvement of sexual function. She also shared an observational study including 103 patients with non-neoplastic epithelial disorders of the vulva who received HIFU treatment and showed some clinical cases.

Prof. Kuan-Gen Huang, president of the Taiwan Association for Minimal Invasive Gynecology discussed the HPV vaccine beyond cervical cancer. Prof. Huang raised that vaccine was the most minimally invasive treatment for cancer. After giving an introduction to human papillomavirus (HPV), he focused on the prevention of cervical cancer and mentioned that HPV vaccination is the primary prevention of cancer, as the cause of cervical cancer is the persistent infection of HPV, which finally leads to pathological changes. He also mentioned that there were many other HPV-associated cancers, including vulvar cancer, vaginal cancer, oropharyngeal cancer, anal cancer and penile cancer.